Cargando…
COVID-19 infection among international travellers: a prospective analysis
OBJECTIVES: This report estimates the risk of COVID-19 importation and secondary transmission associated with a modified quarantine programme in Canada. DESIGN AND PARTICIPANTS: Prospective analysis of international asymptomatic travellers entering Alberta, Canada. INTERVENTIONS: All participants we...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228575/ https://www.ncbi.nlm.nih.gov/pubmed/34168036 http://dx.doi.org/10.1136/bmjopen-2021-050667 |
_version_ | 1783712774241648640 |
---|---|
author | Lunney, Meaghan Ronksley, Paul E Weaver, Robert G Barnieh, Lianne Blue, Norman Avey, Marc T Rolland-Harris, Elizabeth Khan, Faisal M Pang, Jack X Q Rafferty, Ellen Scory, Tayler D Svenson, Lawrence W Rodin, Rachel Tonelli, Marcello |
author_facet | Lunney, Meaghan Ronksley, Paul E Weaver, Robert G Barnieh, Lianne Blue, Norman Avey, Marc T Rolland-Harris, Elizabeth Khan, Faisal M Pang, Jack X Q Rafferty, Ellen Scory, Tayler D Svenson, Lawrence W Rodin, Rachel Tonelli, Marcello |
author_sort | Lunney, Meaghan |
collection | PubMed |
description | OBJECTIVES: This report estimates the risk of COVID-19 importation and secondary transmission associated with a modified quarantine programme in Canada. DESIGN AND PARTICIPANTS: Prospective analysis of international asymptomatic travellers entering Alberta, Canada. INTERVENTIONS: All participants were required to receive a PCR COVID-19 test on arrival. If negative, participants could leave quarantine but were required to have a second test 6 or 7 days after arrival. If the arrival test was positive, participants were required to remain in quarantine for 14 days. MAIN OUTCOME MEASURES: Proportion and rate of participants testing positive for COVID-19; number of cases of secondary transmission. RESULTS: The analysis included 9535 international travellers entering Alberta by air (N=8398) or land (N=1137) that voluntarily enrolled in the Alberta Border Testing Pilot Programme (a subset of all travellers); most (83.1%) were Canadian citizens. Among the 9310 participants who received at least one test, 200 (21.5 per 1000, 95% CI 18.6 to 24.6) tested positive. Sixty-nine per cent (138/200) of positive tests were detected on arrival (14.8 per 1000 travellers, 95% CI 12.5 to 17.5). 62 cases (6.7 per 1000 travellers, 95% CI 5.1 to 8.5; 31.0% of positive cases) were identified among participants that had been released from quarantine following a negative test result on arrival. Of 192 participants who developed symptoms, 51 (26.6%) tested positive after arrival. Among participants with positive tests, four (2.0%) were hospitalised for COVID-19; none required critical care or died. Contact tracing among participants who tested positive identified 200 contacts; of 88 contacts tested, 22 were cases of secondary transmission (14 from those testing positive on arrival and 8 from those testing positive thereafter). SARS-CoV-2 B.1.1.7 lineage was not detected in any of the 200 positive cases. CONCLUSIONS: 21.5 per 1000 international travellers tested positive for COVID-19. Most (69%) tested positive on arrival and 31% tested positive during follow-up. These findings suggest the need for ongoing vigilance in travellers testing negative on arrival and highlight the value of follow-up testing and contact tracing to monitor and limit secondary transmission where possible. |
format | Online Article Text |
id | pubmed-8228575 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-82285752021-06-28 COVID-19 infection among international travellers: a prospective analysis Lunney, Meaghan Ronksley, Paul E Weaver, Robert G Barnieh, Lianne Blue, Norman Avey, Marc T Rolland-Harris, Elizabeth Khan, Faisal M Pang, Jack X Q Rafferty, Ellen Scory, Tayler D Svenson, Lawrence W Rodin, Rachel Tonelli, Marcello BMJ Open Infectious Diseases OBJECTIVES: This report estimates the risk of COVID-19 importation and secondary transmission associated with a modified quarantine programme in Canada. DESIGN AND PARTICIPANTS: Prospective analysis of international asymptomatic travellers entering Alberta, Canada. INTERVENTIONS: All participants were required to receive a PCR COVID-19 test on arrival. If negative, participants could leave quarantine but were required to have a second test 6 or 7 days after arrival. If the arrival test was positive, participants were required to remain in quarantine for 14 days. MAIN OUTCOME MEASURES: Proportion and rate of participants testing positive for COVID-19; number of cases of secondary transmission. RESULTS: The analysis included 9535 international travellers entering Alberta by air (N=8398) or land (N=1137) that voluntarily enrolled in the Alberta Border Testing Pilot Programme (a subset of all travellers); most (83.1%) were Canadian citizens. Among the 9310 participants who received at least one test, 200 (21.5 per 1000, 95% CI 18.6 to 24.6) tested positive. Sixty-nine per cent (138/200) of positive tests were detected on arrival (14.8 per 1000 travellers, 95% CI 12.5 to 17.5). 62 cases (6.7 per 1000 travellers, 95% CI 5.1 to 8.5; 31.0% of positive cases) were identified among participants that had been released from quarantine following a negative test result on arrival. Of 192 participants who developed symptoms, 51 (26.6%) tested positive after arrival. Among participants with positive tests, four (2.0%) were hospitalised for COVID-19; none required critical care or died. Contact tracing among participants who tested positive identified 200 contacts; of 88 contacts tested, 22 were cases of secondary transmission (14 from those testing positive on arrival and 8 from those testing positive thereafter). SARS-CoV-2 B.1.1.7 lineage was not detected in any of the 200 positive cases. CONCLUSIONS: 21.5 per 1000 international travellers tested positive for COVID-19. Most (69%) tested positive on arrival and 31% tested positive during follow-up. These findings suggest the need for ongoing vigilance in travellers testing negative on arrival and highlight the value of follow-up testing and contact tracing to monitor and limit secondary transmission where possible. BMJ Publishing Group 2021-06-24 /pmc/articles/PMC8228575/ /pubmed/34168036 http://dx.doi.org/10.1136/bmjopen-2021-050667 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Infectious Diseases Lunney, Meaghan Ronksley, Paul E Weaver, Robert G Barnieh, Lianne Blue, Norman Avey, Marc T Rolland-Harris, Elizabeth Khan, Faisal M Pang, Jack X Q Rafferty, Ellen Scory, Tayler D Svenson, Lawrence W Rodin, Rachel Tonelli, Marcello COVID-19 infection among international travellers: a prospective analysis |
title | COVID-19 infection among international travellers: a prospective analysis |
title_full | COVID-19 infection among international travellers: a prospective analysis |
title_fullStr | COVID-19 infection among international travellers: a prospective analysis |
title_full_unstemmed | COVID-19 infection among international travellers: a prospective analysis |
title_short | COVID-19 infection among international travellers: a prospective analysis |
title_sort | covid-19 infection among international travellers: a prospective analysis |
topic | Infectious Diseases |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228575/ https://www.ncbi.nlm.nih.gov/pubmed/34168036 http://dx.doi.org/10.1136/bmjopen-2021-050667 |
work_keys_str_mv | AT lunneymeaghan covid19infectionamonginternationaltravellersaprospectiveanalysis AT ronksleypaule covid19infectionamonginternationaltravellersaprospectiveanalysis AT weaverrobertg covid19infectionamonginternationaltravellersaprospectiveanalysis AT barniehlianne covid19infectionamonginternationaltravellersaprospectiveanalysis AT bluenorman covid19infectionamonginternationaltravellersaprospectiveanalysis AT aveymarct covid19infectionamonginternationaltravellersaprospectiveanalysis AT rollandharriselizabeth covid19infectionamonginternationaltravellersaprospectiveanalysis AT khanfaisalm covid19infectionamonginternationaltravellersaprospectiveanalysis AT pangjackxq covid19infectionamonginternationaltravellersaprospectiveanalysis AT raffertyellen covid19infectionamonginternationaltravellersaprospectiveanalysis AT scorytaylerd covid19infectionamonginternationaltravellersaprospectiveanalysis AT svensonlawrencew covid19infectionamonginternationaltravellersaprospectiveanalysis AT rodinrachel covid19infectionamonginternationaltravellersaprospectiveanalysis AT tonellimarcello covid19infectionamonginternationaltravellersaprospectiveanalysis |